About this trial
The purpose of this pilot study: 1) to examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg given 2) to record the time to first analgesic postoperatively and 3) to compare Wong Baker and the 0-10 numeric pain distress scale scores at 12, 24 and 48 hours postoperatively. We hypothesize one 15mg/kg (up to 600mg) dose of gabapentin will decrease mean narcotic amounts in mg/kg compared to participants who do not receive preoperative gabapentin and will demonstrate a decreased mean time to first analgesic as well as to lower mean pain scores for each age group at 12, 24 and 48 hours.
Eligibility criteria
Qualifiers
participants age 3-18 years
ASA class 1 or 2
elective Tonsillectomy/Adenoidectomy
outpatient setting.
Disqualifiers
BMI >40kg/m2
history of renal insufficiency, chronic pain
allergy to gabapentin
history of developmental delay
Trial design
Treatments tested in this trial
- Gabapentin